Eli Lilly plans to launch its experimental oral weight-loss drug orforglipron in India, a senior executive said on Thursday, offering an alternative to injectables that many patients in the world’s most populous nation resist. Orforglipron is part of a new class of GLP-1 drugs that suppress appetite and follow the same pathway targeted by Eli...